Montagna, E. http://orcid.org/0000-0002-0384-0852
Pagan, E.
Bagnardi, V.
Colleoni, M.
Cancello, G.
Munzone, E.
Dellapasqua, S.
Bianco, N.
Campennì, G.
Iorfida, M.
Mazza, M.
De Maio, A.
Veronesi, P.
Sangalli, C.
Scateni, B.
Pettini, G.
Pravettoni, G.
Mazzocco, K.
Galimberti, V.
Article History
Received: 19 January 2020
Accepted: 29 August 2020
First Online: 14 September 2020
Compliance with ethical standards
:
: E Montagna, G. Cancello and E. Munzone had consulting or Advisory Role from Pierre Fabre. M. Mazza received honoraria from Novartis, Pfizer, Istituto Gentili, Celgene, Astrazeneca. M. Colleoni received honoraria from Novartis and had consulting or Advisory Role from Pierre Fabre Pfizer OBI Pharma Puma Biotechnology Celldex AstraZeneca. The other authors declared no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: This article does not contain any studies with animals performed by any of the authors.